Key takeaways

• Life sciences AI programs stall when they cannot convert insights into field execution (the “execution gap”).
• To scale AI in life sciences, embed intelligence directly inside high-volume workflows so decisions and actions happen where the work happens.
• GCCs in life sciences increasingly own AI execution by building, operating and improving commercial and medical workflows with measurable outcomes.
• Agentic AI healthcare needs a unified intelligence platform with harmonized data, compliance-by-design and human oversight so agents can detect, decide and act safely at enterprise scale.

The primary challenge for AI in the life sciences sector is not the development of frontier models, but rather the “execution gap”—the disconnect between organizational intelligence and the ability of field teams to act on it. While many companies have invested in pilots and proof-of-concepts, few have successfully translated these into measurable operational impact.

Across the industry, one pattern is becoming clear: Progress depends less on model sophistication or AI spend and more on whether intelligence is embedded directly into day‑to‑day workflows. This shift is placing life sciences global capability centers (GCCs) at the center of AI execution.

What GCC leaders are seeing on the ground—workflows beat model complexity

During the recent ZAIDYN^® GCC Leadership Summit in Hyderabad, leaders from 14 global life sciences companies identified a consistent pattern among the organizations making the most progress. These winning organizations are focusing on integrating AI into their workflows rather than budget size or model complexity.

These leaders also broadly aligned on a simple but uncomfortable truth: AI initiatives stall when they stop at dashboards, reports or centralized analytics teams.

How GCCs close the execution gap with agentic AI

Historically viewed as back-office enablers, GCCs are now responsible for the workflows that drive commercial and medical strategy. The execution gap persists when intelligence remains trapped in dashboards and reports while field representatives, medical science liaisons (MSLs) and incentive teams continue to rely on manual or outdated processes.

Closing this gap requires shifting intelligence directly into execution. By using unified platforms, organizations can deploy AI agents that operate within existing workflows—sensing signals, recommending decisions and executing actions within established guardrails. This moves the GCC from a support function to a driver of business outcomes.

Pick the workflows that scale AI (and the GCCs already own)

Scaling AI is an operating model challenge. Successful organizations prioritize high-volume, well-defined workflows that are directly tied to business performance. These are the areas where GCCs already possess deep domain expertise:

Commercial workflows

• Incentive compensation (IC): Managing complex payout cycles and error detection
• Field operations: Territory alignment, roster management and call planning
• Omnichannel engagement: Orchestrating customer interactions across multiple digital and physical channels

Medical workflows

• MSL planning: Strategizing deployment and tracking medical impact
• KOL identification: Identifying and engaging key opinion leaders (KOLs) and research interests
• Congress management: Orchestrating follow-ups and data dissemination after major medical events

Results from these deployments are already measurable. One global pharmaceutical company saved $3 million annually by transitioning to a self-serve IC model across 70 markets. Similarly, a global generics leader achieved a 30% reduction in payout turnaround times by consolidating manual operations onto a unified platform.

The architecture of a unified intelligence platform

Agentic AI cannot function effectively in disconnected systems. To be viable at an enterprise scale, AI must be built on a foundation of harmonized data, industry-specific compliance and human-in-the-loop governance.

The objective is to move from reactive reporting to proactive orchestration. A unified platform provides the necessary infrastructure for this shift, offering global standards for consistency while allowing for local configurability. This architecture ensures that HQ leaders can manage execution across diverse markets—such as the U.S., Europe and emerging regions—without fragmenting the underlying data model.

The 3 pillars of agentic AI

The practical application of agentic AI is best understood through the specific functions it performs within a workflow. These functions are categorized into three agent types:

• Monitoring agents (Augment): These agents continuously scan for anomalies and exceptions. In IC, they identify payout errors before they reach the field. In omnichannel marketing, they flag engagement drop-offs in real-time, allowing teams to adjust campaigns before completion.
• Consumption agents (Assist): These agents provide intelligence at the point of action. Instead of waiting for an analyst report, a sales representative receives an immediate breakdown of their performance or an MSL receives an updated profile of a healthcare professional’s research interests immediately before a meeting.
• Execution agents (Act): These agents complete routine tasks on behalf of users, subject to human approval. They can generate call plans, process alignment changes or tag content for medical, legal and regulatory review. This increases the speed and auditability of high-volume tasks.

By operating within governed workflows, these agents ensure that every action is observable and reversible, making the scale of AI operations both fast and trustworthy.

Preparing GCC teams to govern agentic AI

The transition to an AI-driven operating model requires a significant shift in GCC talent. Most teams were originally structured to produce manual outputs; they must now be trained to govern intelligent systems. This transformation involves structured training, “hypercare” support periods, and tight feedback loops between business partners and platform teams.

Human expertise remains the primary safeguard for AI. While agents execute tasks, humans exercise judgment, manage complex exceptions and remain accountable for final outcomes. Trust in AI is earned through consistent governance and tangible results in the field.

The leadership mandate

The implementation of agentic AI in life sciences GCCs is no longer a future state; it is a current reality across commercial and medical functions. For leadership, the mandate is twofold:

• Identify high-impact workflows: Select areas where the business impact is immediate and ownership is clearly defined.
• Define clear success metrics: Move beyond usage statistics to measure adoption rates, cycle times and revenue impact.

The gap between strategy and field impact has long been a hurdle in life sciences. By focusing on the workflow as the unit of scale and leveraging unified platforms, GCCs can finally address this problem at its root—changing not just the data the business uses to act but how the work gets done.